Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMYMP) Revenue (2016 - 2025)

Historic Revenue for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $12.5 billion.

  • Bristol Myers Squibb's Revenue rose 129.64% to $12.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $48.2 billion, marking a year-over-year decrease of 21.95%. This contributed to the annual value of $48.2 billion for FY2025, which is 21.95% down from last year.
  • As of Q4 2025, Bristol Myers Squibb's Revenue stood at $12.5 billion, which was up 129.64% from $12.2 billion recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Revenue peaked at $12.5 billion during Q4 2025, and registered a low of $11.0 billion during Q3 2023.
  • In the last 5 years, Bristol Myers Squibb's Revenue had a median value of $11.7 billion in 2021 and averaged $11.7 billion.
  • In the last 5 years, Bristol Myers Squibb's Revenue surged by 1553.95% in 2021 and then plummeted by 559.63% in 2025.
  • Bristol Myers Squibb's Revenue (Quarter) stood at $12.0 billion in 2021, then decreased by 4.83% to $11.4 billion in 2022, then rose by 0.62% to $11.5 billion in 2023, then rose by 7.54% to $12.3 billion in 2024, then rose by 1.3% to $12.5 billion in 2025.
  • Its Revenue stands at $12.5 billion for Q4 2025, versus $12.2 billion for Q3 2025 and $12.3 billion for Q2 2025.